AVAleksandr A. Vitkov

Aleksandr A. Vitkov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aleksandr A. Vitkov has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Standardization of approaches to repeat glaucoma surgery

    by A. V. Kuroyedov, A. Yu. Brezhnev, E. V. Berdnikova, A. A. Vitkov, D. A. Dorofeev, V. V. Gorodnichii, E. V. Karlova

    Recurrence of sustained intraocular pressure (IOP) elevation occurs in 15% to 35% of cases after glaucoma surgery (GS). The choice of optimal management strategy and timing for repeat GS remains an important and insufficiently studied issue. PURPOSE. To study the range of opinions and clinical approaches among ophthalmologists in Russia regarding repeat glaucoma surgery in patients with primary openangle glaucoma (POAG). METHODS. This study consisted of a survey conducted among 606 ophthalmologists from various regions of Russia. Among them, 432 (71%) worked in outpatient clinics, 96 (16%) in hospitals, and 78 (13%) combined both settings. The study used descriptive statistics and comparison of proportions between groups with assessment of statistical significance (p-values). RESULTS. The vast majority of respondents (77.2% of outpatient physicians and 81.7% of hospital physicians) regularly (weekly, monthly, or quarterly) encounter patients requiring repeat GS. Significant differences in clinical approaches were identified: 46.9% of hospital surgeons were ready to refer patients for repeat surgery within 1.5 to 6 months, whereas only 33.1% of outpatient physicians supported this strategy (p=0.005). In cases of disease destabilization, 46.9% of hospital physicians favor the "prefer repeat surgery" approach, while outpatient physicians more often (42.1%) opted for "prefer prolonged medical therapy" (p=0.0005). While 98.95% of hospital doctors consider stabilization without therapy as a criterion for complete success of antiglaucoma surgery, 6.2% to 8.9% of physicians from other groups also regarded stabilization with hypotensive medications as a successful outcome. CONCLUSION. The survey results revealed significant discrepancies between outpatient and hospital ophthalmologists in the management of patients with failed initial GS, particularly regarding the timing of repeat surgery and the choice between surgical and medical strategies. These findings highlight the absence of unified standards and underscore the need for the development of standardized clinical guidelines for managing this complex patient population to improve long-term functional outcomes.

  • Features of medical and surgical treatment of normal-tension glaucoma

    by A. A. Vitkov, N. G. Glazko, N. A. Bakunina, A. V. Seleznev, A. Yu. Brezhnev, A. V. Kuroyedov

    Normal-tension glaucoma is a progressive optic neuropathy characterized by thinning of the peripapillary retinal nerve fiber layer and the development of typical visual field defects, open anterior chamber angle, and intraocular pressure levels that do not exceed the statistically normal range. The course of this disease differs from that of hypertensive glaucoma by the presence of more localized and deeper defects of light sensitivity, as well as by a higher rate of progression. The management of normal-tension glaucoma (medical, laser, or surgical) is aimed at reducing intraocular pressure and achieving target levels at which further loss of visual function can be halted. A distinctive feature of the therapeutic approach to this form of glaucoma is the need for lower target intraocular pressure values, which, in combination with the high rate of disease progression, necessitates a more rapid transition to surgical treatment. The challenge of normal-tension glaucoma lies in its diagnostic features, clinical manifestations, and treatment strategies, all of which require a differentiated and personalized approach. This literature review analyzes current data on the morphological and functional differences between normaltension glaucoma and typical primary open-angle glaucoma, evaluates the effectiveness of various pharmacological classes of hypotensive medications, and examines modern trends in the surgical management of this disease.

  • Comparative evaluation of tonometry methods in keratoconus

    by S.E. Avetisov, V.V. Averich, A.V. Volzhanin, A.A. Antonov, T.E. Borisenko, D.V. Kosova, A.A. Vitkov, E.A. Budnikova

    The chronic course of keratoconus (KC) and the associated structural and functional changes in the cornea complicate the interpretation of intraocular pressure (IOP) measurements. A promising approach is to analyze tonometric data with consideration of the variability of corneal biomechanical (viscoelastic) properties and thickness rather than disease stage. This is supported by clinical observations showing a wide variation in IOP values even within the same stage of KC. Purpose. This study aimed to comparatively evaluate tonometric readings obtained by different devices in KC based on corneal biomechanical characteristics and thickness. Material and methods. A total of 167 patients (334 eyes) with bilateral KC (mean age 31.0±8.8 years) were examined. Three subgroups were formed according to data from bidirectional pneumotonometry (Ocular Response Analyzer, ORA) and non-contact tonometry (Corvis ST with Scheimpflug imaging), taking into account corneal hysteresis (CH), corneal resistance factor (CRF), and central corneal thickness (CCT). IOP was measured by pneumotonometry, bidirectional pneumotonometry (ORA), rebound tonometry (RT), dynamic contour tonometry (DCT), and Maklakov tonometry. The analysis assumed that, excluding structural changes in the cornea in young subjects, differences in IOP values between subgroups would be minimal. Thus, the observed deviations were attributed mainly to biomechanical changes in KC, where lower tonometric readings reflected greater dependence of IOP on the degree of corneal deformation. Results. Statistically significant differences (p<0.05) in tonometry readings between subgroups confirmed the substantial impact of corneal biomechanical parameters and thickness on IOP measurements in KC. The greatest variability (39—50%) was observed with pneumotonometry and bidirectional pneumotonometry (Goldmann-correlated IOP, IOPg, by ORA). In these cases, lower IOP values correlated with poorer biomechanical status of the cornea and lower CCT. For other methods (corneal-compensated IOP (IOPcc) by ORA, RT, DCT, and Maklakov tonometry), the variability was less pronounced and did not exceed 26%. Conclusion. Regardless of the method used to assess intraocular pressure, alterations in corneal biomechanics in KC result in underestimation of IOP values.

  • Open Access

    Excessive scarring in glaucoma surgery. Part 2: Anti-inflammatory therapy, antimetabolites, angiogenesis inhibitors

    by Yu. Yusef, А. А. Antonov, А. М. Subbot, I. I. Vitkova, E. V. Emets, A. A. Vitkov, Ю. Юсеф

    The main complication of glaucoma surgery is excessive scarring of newly created aqueous humor outflow pathways. To prevent fibrotic tissue formation, medications with different mechanisms of action are used intraoperatively and during the early postoperative period.The primary group of anti-inflammatory drugs used in glaucoma surgery are topical steroids. A particularly high antiinflammatory efficacy has been demonstrated with a slowrelease dexamethasone implant placed under the scleral flap.Nonsteroidal anti-inflammatory drugs, in addition to their direct effect, can potentiate the hypotensive action of prostaglandin analogs and reduce the severity of their local side effects. The use of antimetabolites such as mitomycin C and 5-fluorouracil is justified by their antifibrotic activity, which inhibits DNA synthesis and, consequently, the proliferation of cells including myofibroblasts. However, they are associated with a high risk of hypotonic complications. Angiogenesis inhibitors suppress vascular endothelial growth factor production and thus block proliferation.The use of ranibizumab, bevacizumab, and infliximab as adjuncts to standard therapy can enhance the longterm effectiveness of glaucoma surgery. However, their use remains limited and not fully explored.


  • Ciliochoroidal detachment as a complication of glaucoma surgery. Part 2. Treatment and prevention

    by Yu. Yusef, A.A. Antonov, A.A. Vitkov, A.A. Komarov, I.V. Kozlova

    The introduction of new methods of surgical treatment of glaucoma reduces the risks, but does not exclude the development of choroidal detachment. The incidence of this complication has been reduced thanks to microinvasive techniques. This article analyzes the most widely recognized medical and surgical approaches to the treatment of ciliochoroidal detachment. The correct choice of preventive measures may help reduce the occurrence of this complication of glaucoma surgery.

  • Ciliochoroidal detachment as a complication of glaucoma surgery. Part 1. Theories of pathogenesis, symptoms and diagnosis

    by Yu. Yusef, A.A. Antonov, A.A. Vitkov, A.A. Komarov, I.V. Kozlova

    Choroidal detachment is one of the most common complications of glaucoma surgery. It frequently develops following filtering and drainage glaucoma operations, as well as some laser interventions. The onset of this condition is associated with a variety of factors, most notably fluctuations in intraocular pressure and the anatomical and biomechanical features of the eye. This article reviews the main theories of pathogenesis, symptoms and diagnosis12 of this pathology. Understanding the underlying pathogenetic mechanisms of ciliochoroidal detachment is essential for ophthalmologists to ensure proper management and prevention of this condition.

  • Open Access

    Excessive scarring in glaucoma surgery. Part 1: Current concepts of wound healing in glaucoma surgery

    by Yu. N. Yusef, А. А. Antonov, А. М. Subbot, I. I. Vitkova, E. V. Emets, A. A. Vitkov, E. D. Semenov, Ю. Н. Юсеф

    The main complication of glaucoma surgery is cicatricial changes in newly formed outflow tracts. This process leads to a repeated increase in intraocular pressure (IOP) and is the reason for a decrease in the effectiveness of glaucoma surgeries. In the cascade of successive stages of surgical wound healing, the inflammation phase is considered the most important. Reducing its severity and duration is the main goal of postoperative therapy, since excessive inflammation leads to the formation of scar tissues. In turn, its excessive suppression leads to the development of "ineffective resolution". In this case, the inflammation becomes chronic, and the next healing phase does not occur. For complete restoration of the damaged tissue architecture, the healing process must consistently go through all phases. The use of pro-resolving mediators can contribute to the correct completion of inflammation.This review explores the physiological processes of restoration of the damaged tissue architecture, as well as the causes of cicatricial changes in the newly formed intraocular fluid outflow tracts.


  • Changes in the ocular surface condition during the transition to preservative-free hypotensive combination therapy in the long-term observation of patients with advanced stages of glaucoma

    by Dmitry A. Dorofeev, Aleksandr A. Vitkov, Elena V. Kirilik, Ksenia O. Lukyanova, Olga G. Pozdeeva

    Overview — Elevated intraocular pressure (IOP) is the main risk factor for the development and progression of primary open-angle glaucoma (POAG). Topical drugs, along with laser and surgical treatment options, are among the methods of IOP reduction. In most cases, topical hypotensive therapy is considered the first stage of glaucoma treatment. The transition to other treatment methods often occurs due to the ineffectiveness of long-term combination therapy. Most of the drugs used contain a preservative, which can negatively affect the condition of the ocular surface. The use of preservative-free fixed combinations (FC) can improve it with a similar hypotensive effect. Objective — To study the condition of the ocular surface when replacing the preserved FC of brinzolamide 1%/timolol 0.5% with a preservative-free FC of tafluprost 0.0015%/timolol 0.5%. Material and Methods — Group 1 (observation group) included patients with POAG in 20 (20.6%) eyes. Group 2 (control) included individuals without glaucoma who did not receive topical therapy in 77 (71%) eyes. The final study protocol included observational data at the time of inclusion in the study, as well as 1 month and 1 year after replacing the preserved FC of brinzolamide 1%/timolol 0.5% to the preservative-free FC of tafluprost 0.0015%/timolol 0.5%. All patients underwent a standard ophthalmological examination and assessment of structural and functional parameters, as well as examination of their ocular surface condition via the Norn test, Schirmer test, lissamine green vital staining, the Ocular Surface Disease Index (OSDI) questionnaire, and meniscometry 1 month and 1 year after the onset of the study. Results — Results: No statistically significant changes in IOP were observed after switching from the preserved FC of brinzolamide 1%/timolol 0.5% to the preservative-free FC of tafluprost 0.0015%/timolol 0.5% (from 13.4±2.7 to 13.4±3.2 mmHg after 1 month and to 15.3±4.4 mmHg after 1 year). At all checkpoints, the condition of the ocular surface was similar between the groups (p>0.05) for all parameters, except for the OSDI questionnaire. After 1 month and 1 year of observation, no significant changes in the ocular surface were found in the groups using preservative-free Tapticom ® (Santen, Japan), except for the OSDI questionnaire after 1 year. The ratio of the tear meniscus depth and height based on OCT meniscometry data statistically significantly differed between the groups. Conclusion — Long-term use of preservative-free Tapticom ® allowed effectively reducing the IOP to target values. This helped stabilizing structural and functional parameters without causing additional changes in the condition of the ocular surface. The transition from long-term treatment with preserved medications to preservative-free drug forms does not always lead to an improvement in the condition of the eyes. This may be due to a chronic process provoked by the preservative. Prescribing preservative-free therapy at the onset of treatment allows reducing the risk of developing dry eye syndrome and diminishing the subjective sensations in patients during long-term hypotensive therapy.

  • Influence of perioperative therapy on filtration bleb formation and ophthalmotonus level after glaucoma surgery

    by A. A. Antonov, A. A. Vitkov, A. S. Makarova, R. P. Poleva, I. I. Vitkova

    Introduction. One limitation of glaucoma surgery is its reduced long-term effectiveness due to scarring of intraocular fluid outflow pathways. Appropriate perioperative therapy may extend the hypotensive effect by reducing scarring and improving the filtration bleb. Purpose: to evaluate the effect of perioperative use of Oku-Oku® on intraocular pressure (IOP) and filtration bleb condition in the early postoperative period following glaucoma surgery. Materials and methods. Thirty patients (30 eyes) who underwent non-penetrating glaucoma surgery (NPGS) were studied. The main group (15 eyes) received Oku-Oku® drops twice daily: the day before surgery, immediately before surgery, and for five days postoperatively. The control group (15 eyes) received no additional medication. Tonometry and assessment of conjunctival hyperemia were performed the day before surgery, and at 1 day, 2 weeks, and 1 month postoperatively. Filtration bleb characteristics were assessed using the Würzburg Clinical and Morphological Classification of Filtration Pads at the same time points, except for the preoperative assessment. Results. Glaucoma surgery significantly reduced IOP in both groups. After 1 month, the mean IOP in the main group was lower (15.1 ± 4.1 mm Hg) compared to the control group (17.9 ± 3.3 mm Hg). Conjunctival hyperemia was also lower in the main group (15.4 ± 2.7%) than in the control group (18.0 ± 3.1%). Filtration bleb parameters improved in both groups over time, with the greatest differences observed at 1 day and 2 weeks post-surgery. Conclusion. Perioperative use of Oku-Oku® reduced conjunctival hyperemia in the filtration bleb area during the first month after glaucoma surgery. This early improvement in the intraocular fluid deposition area may enhance the effectiveness of glaucoma surgery. Oku-Oku® can be used in comprehensive preparation for glaucoma surgery and other similar anterior segment procedures.


  • Reproducibility Of Retinal Nerve Fiber Layer And Macular Volume Measurements In Patients Receiving Retinal Protection Pharmacotherapy

    by Dmitry A. Dorofeev, Aleksey A. Antonov, Irina V. Kozlova, Elena V. Kirilik, Lukyanova Ksenia O., Olga G. Pozdeeva, Olga B. Solovieva, Artem Z. Tsyganov

    Background — High-quality monitoring of the glaucoma plays an important role in the early diagnosis and treatment of glaucoma, for which structural optical coherence tomography (OCT) is used. Technology that increases the repeatability and reproducibility of OCT may differ in different devices, thereby yielding different results. Objective — To assess the effect of the frequency of retinal protection pharmacotherapy courses on quantitative data regarding the macular volume and the thickness of the retinal nerve fiber layer (RNFL) measured by two instruments, SPECTRALIS and OPTOPOL, and also to evaluate the agreement between the data collected by these devices. Material and Methods — We monitored 17 patients (34 eyes) diagnosed with primary open-angle glaucoma in the advanced stage from 2019 to 2023. Group 1 including 9 patients (18 eyes) received a course of retinal protection pharmacotherapy with Retinalamin® at an interval of 3 months, while Group 2 comprising 8 patients (16 eyes) received similar treatment at an interval of 6 months. All observed patients underwent structural OCT on REVO NX (OPTOPOL Technology) and SPECTRALIS devices at the onset of the study, as well as after 3 and 6 months. Results — The agreement between the two devices in measuring RNFL thickness was estimated by the Lin’s concordance correlation coefficient (LCCC): in manual mode, LCCCstart=0.69 (95% CI: 0.51-0.81); while in automatic mode, LCCCstart=0.73 (95% CI: 0.57-0.84). The agreement between the macular volume measurements was as follows: in manual mode, LCCCstart=0.21 (95% CI: 0.21-0.29); while in automatic mode, LCCCstart=0.21 (95% CI: 0.21-0.29). Conclusion — The agreement between the SPECTRALIS and OPTOPOL devices in terms of RNFL thickness should be considered substantial, while in terms of macular volume, it should be classified as fair. As measured in the manual mode, the RNFL thickness in both groups receiving Retinalamin increased, which can be interpreted as a favorable effect of retinal protection pharmacotherapy.